309 related articles for article (PubMed ID: 34398244)
1. Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
Barlev-Gross M; Weiss S; Paran N; Yahalom-Ronen Y; Israeli O; Nemet I; Kliker L; Zuckerman N; Glinert I; Noy-Porat T; Alcalay R; Rosenfeld R; Levy H; Mazor O; Mandelboim M; Mendelson E; Beth-Din A; Israely T; Mechaly A
J Infect Dis; 2021 Aug; 224(4):616-619. PubMed ID: 34398244
[TBL] [Abstract][Full Text] [Related]
2. Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.
La Rosa G; Mancini P; Bonanno Ferraro G; Veneri C; Iaconelli M; Lucentini L; Bonadonna L; Brusaferro S; Brandtner D; Fasanella A; Pace L; Parisi A; Galante D; Suffredini E
Water Res; 2021 Jun; 197():117104. PubMed ID: 33857895
[TBL] [Abstract][Full Text] [Related]
3. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2.
Saade C; Gonzalez C; Bal A; Valette M; Saker K; Lina B; Josset L; Trabaud MA; Thiery G; Botelho-Nevers E; Paul S; Verhoeven P; Bourlet T; Pillet S; Morfin F; Trouillet-Assant S; Pozzetto B; On Behalf Of Covid-Ser Study Group
Emerg Microbes Infect; 2021 Dec; 10(1):1499-1502. PubMed ID: 34176436
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
Li Q; Nie J; Wu J; Zhang L; Ding R; Wang H; Zhang Y; Li T; Liu S; Zhang M; Zhao C; Liu H; Nie L; Qin H; Wang M; Lu Q; Li X; Liu J; Liang H; Shi Y; Shen Y; Xie L; Zhang L; Qu X; Xu W; Huang W; Wang Y
Cell; 2021 Apr; 184(9):2362-2371.e9. PubMed ID: 33735608
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations.
Gladkikh A; Dolgova A; Dedkov V; Sbarzaglia V; Kanaeva O; Popova A; Totolian A
Viruses; 2021 May; 13(6):. PubMed ID: 34072569
[TBL] [Abstract][Full Text] [Related]
6. Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.
Singh J; Samal J; Kumar V; Sharma J; Agrawal U; Ehtesham NZ; Sundar D; Rahman SA; Hira S; Hasnain SE
Viruses; 2021 Mar; 13(3):. PubMed ID: 33803400
[TBL] [Abstract][Full Text] [Related]
7. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.
Riddell S; Goldie S; McAuley AJ; Kuiper MJ; Durr PA; Blasdell KR; Tachedjian M; Druce JD; Smith TRF; Broderick KE; Vasan SS
Front Immunol; 2021; 12():694857. PubMed ID: 34248993
[TBL] [Abstract][Full Text] [Related]
8. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
Jia Z; Gong W
J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
[TBL] [Abstract][Full Text] [Related]
9. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
[TBL] [Abstract][Full Text] [Related]
10. Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.
Chaqroun A; Hartard C; Schvoerer E
Viruses; 2021 Jun; 13(6):. PubMed ID: 34207378
[TBL] [Abstract][Full Text] [Related]
11. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.
Slavov SN; Patané JSL; Bezerra RDS; Giovanetti M; Fonseca V; Martins AJ; Viala VL; Rodrigues ES; Santos EV; Barros CRS; Marqueze EC; Santos B; Aburjaile F; Neto RM; Moretti DB; Haddad R; Calado RT; Kitajima JP; Freitas E; Schlesinger D; Junior de Alcantara LC; Elias MC; Sampaio SC; Kashima S; Covas DT
J Med Virol; 2021 Dec; 93(12):6782-6787. PubMed ID: 34241897
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
[TBL] [Abstract][Full Text] [Related]
13. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.
Touret F; Luciani L; Baronti C; Cochin M; Driouich JS; Gilles M; Thirion L; Nougairède A; de Lamballerie X
mBio; 2021 Aug; 12(4):e0085021. PubMed ID: 34225487
[TBL] [Abstract][Full Text] [Related]
14. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
Teyssou E; Soulie C; Visseaux B; Lambert-Niclot S; Ferre V; Marot S; Jary A; Sayon S; Zafilaza K; Leducq V; Schnuriger A; Abdi B; Wirden M; Houhou-Fidouh N; Charpentier C; Morand-Joubert L; Burrel S; Descamps D; Calvez V; Marcelin AG
J Infect; 2021 Jul; 83(1):119-145. PubMed ID: 33932451
[No Abstract] [Full Text] [Related]
15. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.
Maggi F; Novazzi F; Genoni A; Baj A; Spezia PG; Focosi D; Zago C; Colombo A; Cassani G; Pasciuta R; Tamborini A; Rossi A; Prestia M; Capuano R; Azzi L; Donadini A; Catanoso G; Grossi PA; Maffioli L; Bonelli G
Emerg Infect Dis; 2021 Apr; 27(4):1249-1251. PubMed ID: 33567246
[TBL] [Abstract][Full Text] [Related]
16. Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy.
Novazzi F; Genoni A; Spezia PG; Focosi D; Zago C; Colombo A; Cassani G; Pasciuta R; Tamborini A; Rossi A; Prestia M; Capuano R; Gasperina DD; Dentali F; Severgnini P; Ageno W; Gambarini C; Stefanelli P; Baj A; Maggi F
Emerg Microbes Infect; 2021 Dec; 10(1):710-712. PubMed ID: 33739917
[TBL] [Abstract][Full Text] [Related]
17. Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants' spike protein-an in silico analysis.
Pokhrel S; Kraemer BR; Lee L; Samardzic K; Mochly-Rosen D
PLoS One; 2021; 16(5):e0251426. PubMed ID: 34038453
[TBL] [Abstract][Full Text] [Related]
18. The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?
Guo S; Liu K; Zheng J
Int J Biol Sci; 2021; 17(6):1476-1485. PubMed ID: 33907511
[TBL] [Abstract][Full Text] [Related]
19. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
Vogels CBF; Breban MI; Ott IM; Alpert T; Petrone ME; Watkins AE; Kalinich CC; Earnest R; Rothman JE; Goes de Jesus J; Morales Claro I; Magalhães Ferreira G; Crispim MAE; ; Singh L; Tegally H; Anyaneji UJ; ; Hodcroft EB; Mason CE; Khullar G; Metti J; Dudley JT; MacKay MJ; Nash M; Wang J; Liu C; Hui P; Murphy S; Neal C; Laszlo E; Landry ML; Muyombwe A; Downing R; Razeq J; de Oliveira T; Faria NR; Sabino EC; Neher RA; Fauver JR; Grubaugh ND
PLoS Biol; 2021 May; 19(5):e3001236. PubMed ID: 33961632
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Wibmer CK; Ayres F; Hermanus T; Madzivhandila M; Kgagudi P; Oosthuysen B; Lambson BE; de Oliveira T; Vermeulen M; van der Berg K; Rossouw T; Boswell M; Ueckermann V; Meiring S; von Gottberg A; Cohen C; Morris L; Bhiman JN; Moore PL
Nat Med; 2021 Apr; 27(4):622-625. PubMed ID: 33654292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
